![Andres McAllister](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 7 139 $ au 31/08/2026
Andres McAllister is currently Chief Medical Officer at BioInvent International AB since 2017.
Former positions include Director-Research & Development at Immune Design Corp., Non-Executive Director at Immunexpress Pty Ltd., Principal at Institut Pasteur, Chief Scientific Officer at Debiopharm International SA from 2004 to 2015, Principal at The University of California, San Francisco, and Principal at Centre d'Immunologie Pierre Fabre.
Education includes doctorates from Université Paris 1 Panthéon-Sorbonne and Universidad del Rosario.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 3 009 ( 0 % ) | 7 139 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BIOINVENT INTERNATIONAL AB | Directeur Technique/Scientifique/R&D | 01/01/2017 |
| Sociétés | Poste | Fin |
|---|---|---|
Debiopharm International SA
 Debiopharm International SA BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops drugs to cure cancer and infectious diseases | Directeur Technique/Scientifique/R&D | 01/09/2015 |
Immunexpress Pty Ltd.
 Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Engages in creating molecular diagnostics for sepsis | Directeur/Membre du Conseil | - |
Centre d'Immunologie Pierre Fabre | Corporate Officer/Principal | - |
Institut Pasteur
 Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Corporate Officer/Principal | - |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
BioInvent International AB
 BioInvent International AB BiotechnologyHealth Technology Develops and manufactures immunomodulatory antibodies for cancer treatment | Health Technology |
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Debiopharm International SA
Debiopharm International SA BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops drugs to cure cancer and infectious diseases | Health Technology |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Paris 1 Panthéon-Sorbonne
 Université Paris 1 Panthéon-Sorbonne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Immunexpress Pty Ltd.
Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Engages in creating molecular diagnostics for sepsis | Health Technology |
Universidad del Rosario
 Universidad del Rosario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centre d'Immunologie Pierre Fabre |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
